Resat Kendir

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Rituximab is a monoclonal antibody which targets CD20 in B cells that is used for the treatment of CD20 positive oncologic and hematologic malignancies. Rituximab causes hypersensitivity reactions during infusions. The delay of treatment or loss of a highly efficient drug can be prevented by rapid drug desensitization method in patients who are allergic to(More)
  • 1